AI Metrics wins FDA nod for liver biopsy software

2019 05 29 19 22 3353 Liver Anatomy 400

Artificial intelligence (AI) software developer AI Metrics has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its Liver Surface Nodularity (LSN) virtual liver biopsy software.

Designed to assist physicians in staging chronic liver disease, LSN's algorithms assess nodules along the liver's surface on CT images, according to the vendor. The software module will be distributed by AI Metrics partner Imaging Biometrics.

The FDA clearance is the first for AI Metrics.

Page 1 of 549
Next Page